Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 603 entries
Sorted by: Best Match Show Resources per page
Effect of cyclic AMP on fructose utilization, progressive motility and protein synthesis by ram spermatozoa.

Theriogenology

Salem MH, Mekkawy MY, Ahmed NA, Abdel-Aziz IY, Mohamed AA, El-Oksh HA, Pursel VG.
PMID: 16727104
Theriogenology. 1992 May;37(5):1061-74. doi: 10.1016/0093-691x(92)90104-y.

Ejaculated washed ram spermatozoa showed consistent increases in the intracellular concentration of cyclic 3', 5'-adenosine monophosphate (cAMP) after incubation for 15 minutes with the phosphodiesterase (PDE)-inhibitors, theophylline and caffeine. In vitro addition of cAMP or PDE-inhibitors to ram semen...

Cite
Salem MH, Mekkawy MY, Ahmed NA, et al. Effect of cyclic AMP on fructose utilization, progressive motility and protein synthesis by ram spermatozoa. Theriogenology. 1992;37(5):1061-74doi: 10.1016/0093-691x(92)90104-y.
Salem, M. H., Mekkawy, M. Y., Ahmed, N. A., Abdel-Aziz, I. Y., Mohamed, A. A., El-Oksh, H. A., & Pursel, V. G. (1992). Effect of cyclic AMP on fructose utilization, progressive motility and protein synthesis by ram spermatozoa. Theriogenology, 37(5), 1061-74. https://doi.org/10.1016/0093-691x(92)90104-y
Salem, M H, et al. "Effect of cyclic AMP on fructose utilization, progressive motility and protein synthesis by ram spermatozoa." Theriogenology vol. 37,5 (1992): 1061-74. doi: https://doi.org/10.1016/0093-691x(92)90104-y
Salem MH, Mekkawy MY, Ahmed NA, Abdel-Aziz IY, Mohamed AA, El-Oksh HA, Pursel VG. Effect of cyclic AMP on fructose utilization, progressive motility and protein synthesis by ram spermatozoa. Theriogenology. 1992 May;37(5):1061-74. doi: 10.1016/0093-691x(92)90104-y. PMID: 16727104.
Copy Download .nbib Format: NLM
Regulation of insulin release from isolated islets of Langerhans of the rat in pregnancy. The role of adenosine 3':5'-cyclic monophosphate.

The Biochemical journal

Green IC, Howell SL, Montague W, Taylor KW.
PMID: 16742808
Biochem J. 1973 Jun;134(2):481-7. doi: 10.1042/bj1340481.

1. The concentrations of cyclic AMP were compared in islets of Langerhans isolated from the pancreases of normal female and pregnant rats and were higher in islets in pregnancy. 2. There was also a significant increase in adenylate cyclase...

Cite
Green IC, Howell SL, Montague W, et al. Regulation of insulin release from isolated islets of Langerhans of the rat in pregnancy. The role of adenosine 3':5'-cyclic monophosphate. Biochem J. 1973;134(2):481-7doi: 10.1042/bj1340481.
Green, I. C., Howell, S. L., Montague, W., & Taylor, K. W. (1973). Regulation of insulin release from isolated islets of Langerhans of the rat in pregnancy. The role of adenosine 3':5'-cyclic monophosphate. The Biochemical journal, 134(2), 481-7. https://doi.org/10.1042/bj1340481
Green, I C, et al. "Regulation of insulin release from isolated islets of Langerhans of the rat in pregnancy. The role of adenosine 3':5'-cyclic monophosphate." The Biochemical journal vol. 134,2 (1973): 481-7. doi: https://doi.org/10.1042/bj1340481
Green IC, Howell SL, Montague W, Taylor KW. Regulation of insulin release from isolated islets of Langerhans of the rat in pregnancy. The role of adenosine 3':5'-cyclic monophosphate. Biochem J. 1973 Jun;134(2):481-7. doi: 10.1042/bj1340481. PMID: 16742808; PMCID: PMC1177834.
Copy Download .nbib Format: NLM
Effect of phenylpyruvate on enzymes involved in fatty acid synthesis in rat brain.

The Biochemical journal

Deery DJ, Taylor KW.
PMID: 16742817
Biochem J. 1973 Jun;134(2):557-63. doi: 10.1042/bj1340557.

1. The effects of azaserine and nicotinamide, agents which inhibit and stimulate hepatic NAD synthesis respectively, on the content of NAD(+) and NADH in isolated rat islets of Langerhans incubated in vitro were studied. The effects of these compounds...

Cite
Deery DJ, Taylor KW. Effect of phenylpyruvate on enzymes involved in fatty acid synthesis in rat brain. Biochem J. 1973;134(2):557-63doi: 10.1042/bj1340557.
Deery, D. J., & Taylor, K. W. (1973). Effect of phenylpyruvate on enzymes involved in fatty acid synthesis in rat brain. The Biochemical journal, 134(2), 557-63. https://doi.org/10.1042/bj1340557
Deery, D J, and Taylor, K W. "Effect of phenylpyruvate on enzymes involved in fatty acid synthesis in rat brain." The Biochemical journal vol. 134,2 (1973): 557-63. doi: https://doi.org/10.1042/bj1340557
Deery DJ, Taylor KW. Effect of phenylpyruvate on enzymes involved in fatty acid synthesis in rat brain. Biochem J. 1973 Jun;134(2):557-63. doi: 10.1042/bj1340557. PMID: 16742817; PMCID: PMC1177843.
Copy Download .nbib Format: NLM
CTAD as a universal anticoagulant.

Journal of automated methods & management in chemistry

Yokota M, Tatsumi N, Tsuda I, Nishioka T, Takubo T.
PMID: 18924886
J Autom Methods Manag Chem. 2003;25(1):17-20. doi: 10.1155/S1463924603000038.

The feasibility of CTAD (a mixture of citrate, theophylline, adenosine and dipyridamole) as a new anticoagulant for medical laboratory use was studied prospectively. Whole blood anticoagulated with CTAD exhibited results very similar to those of blood anticoagulated with EDTA...

Cite
Yokota M, Tatsumi N, Tsuda I, et al. CTAD as a universal anticoagulant. J Autom Methods Manag Chem. 2003;25(1):17-20doi: 10.1155/S1463924603000038.
Yokota, M., Tatsumi, N., Tsuda, I., Nishioka, T., & Takubo, T. (2003). CTAD as a universal anticoagulant. Journal of automated methods & management in chemistry, 25(1), 17-20. https://doi.org/10.1155/S1463924603000038
Yokota, M, et al. "CTAD as a universal anticoagulant." Journal of automated methods & management in chemistry vol. 25,1 (2003): 17-20. doi: https://doi.org/10.1155/S1463924603000038
Yokota M, Tatsumi N, Tsuda I, Nishioka T, Takubo T. CTAD as a universal anticoagulant. J Autom Methods Manag Chem. 2003;25(1):17-20. doi: 10.1155/S1463924603000038. PMID: 18924886; PMCID: PMC2548379.
Copy Download .nbib Format: NLM
Prediction of selectivity coefficients of a theophylline-selective electrode using MLR and ANN.

Talanta

Riahi S, Mousavi MF, Shamsipur M.
PMID: 18970631
Talanta. 2006 May 15;69(3):736-40. doi: 10.1016/j.talanta.2005.11.010. Epub 2005 Dec 13.

The selectivity coefficient of 24 interfering compounds (drugs, amino acids and organic compounds) of a theophylline-selective electrode was predicted using an artificial neural network (ANN). The multiple linear regression (MLR) technique was used to select the descriptors as inputs...

Cite
Riahi S, Mousavi MF, Shamsipur M. Prediction of selectivity coefficients of a theophylline-selective electrode using MLR and ANN. Talanta. 2005;69(3):736-40doi: 10.1016/j.talanta.2005.11.010.
Riahi, S., Mousavi, M. F., & Shamsipur, M. (2006). Prediction of selectivity coefficients of a theophylline-selective electrode using MLR and ANN. Talanta, 69(3), 736-40. https://doi.org/10.1016/j.talanta.2005.11.010
Riahi, S, et al. "Prediction of selectivity coefficients of a theophylline-selective electrode using MLR and ANN." Talanta vol. 69,3 (2006): 736-40. doi: https://doi.org/10.1016/j.talanta.2005.11.010
Riahi S, Mousavi MF, Shamsipur M. Prediction of selectivity coefficients of a theophylline-selective electrode using MLR and ANN. Talanta. 2006 May 15;69(3):736-40. doi: 10.1016/j.talanta.2005.11.010. Epub 2005 Dec 13. PMID: 18970631.
Copy Download .nbib Format: NLM
Determination of theophylline in plasma by oxidation at the stationary carbon-paste electrode.

Talanta

Munson JW, Abdine H.
PMID: 18962243
Talanta. 1978 Apr;25(4):221-2. doi: 10.1016/0039-9140(78)80008-3.

A method for the determination of the concentration of theophylline in plasma at therapeutic levels is described. The method is based on the oxidation of theophylline at the stationary carbon-paste electrode and involves a simple extraction procedure and differential...

Cite
Munson JW, Abdine H. Determination of theophylline in plasma by oxidation at the stationary carbon-paste electrode. Talanta. 1978;25(4):221-2doi: 10.1016/0039-9140(78)80008-3.
Munson, J. W., & Abdine, H. (1978). Determination of theophylline in plasma by oxidation at the stationary carbon-paste electrode. Talanta, 25(4), 221-2. https://doi.org/10.1016/0039-9140(78)80008-3
Munson, J W, and Abdine, H. "Determination of theophylline in plasma by oxidation at the stationary carbon-paste electrode." Talanta vol. 25,4 (1978): 221-2. doi: https://doi.org/10.1016/0039-9140(78)80008-3
Munson JW, Abdine H. Determination of theophylline in plasma by oxidation at the stationary carbon-paste electrode. Talanta. 1978 Apr;25(4):221-2. doi: 10.1016/0039-9140(78)80008-3. PMID: 18962243.
Copy Download .nbib Format: NLM
When asthma interrupts sleep in children: what is the best strategy?.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Steenhuis TJ, Landstra AM, Verberne AA, van Aalderen WM.
PMID: 18031192
BioDrugs. 1999 Dec;12(6):431-8. doi: 10.2165/00063030-199912060-00003.

Nocturnal symptoms of asthma such as coughing, wheezing, dyspnoea and dyspnoea on awakening are common in children with asthma. This is an important issue since nocturnal symptoms may have a negative influence on the child's life, affecting, for example,...

Cite
Steenhuis TJ, Landstra AM, Verberne AA, et al. When asthma interrupts sleep in children: what is the best strategy?. BioDrugs. 1999;12(6):431-8doi: 10.2165/00063030-199912060-00003.
Steenhuis, T. J., Landstra, A. M., Verberne, A. A., & van Aalderen, W. M. (1999). When asthma interrupts sleep in children: what is the best strategy?. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 12(6), 431-8. https://doi.org/10.2165/00063030-199912060-00003
Steenhuis, T J, et al. "When asthma interrupts sleep in children: what is the best strategy?." BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy vol. 12,6 (1999): 431-8. doi: https://doi.org/10.2165/00063030-199912060-00003
Steenhuis TJ, Landstra AM, Verberne AA, van Aalderen WM. When asthma interrupts sleep in children: what is the best strategy?. BioDrugs. 1999 Dec;12(6):431-8. doi: 10.2165/00063030-199912060-00003. PMID: 18031192.
Copy Download .nbib Format: NLM
Geriatric prescribing in the medical wards of a teaching hospital in Nepal.

Pharmacoepidemiology and drug safety

Joshi MP, Sugimoto T, Santoso B.
PMID: 15073762
Pharmacoepidemiol Drug Saf. 1997 Nov;6(6):417-21. doi: 10.1002/(SICI)1099-1557(199711/12)6:6<417::AID-PDS279>3.0.CO;2-J.

A retrospective study on prescribing patterns for 100 randomly selected geriatric patients admitted over a period of 1 year to the medical wards of the Tribhuvan University Teaching Hospital (TUTH) in Nepal showed that polypharmacy was prevalent. During a...

Cite
Joshi MP, Sugimoto T, Santoso B. Geriatric prescribing in the medical wards of a teaching hospital in Nepal. Pharmacoepidemiol Drug Saf. 1997;6(6):417-21doi: 10.1002/(SICI)1099-1557(199711/12)6:6<417::AID-PDS279>3.0.CO;2-J.
Joshi, M. P., Sugimoto, T., & Santoso, B. (1997). Geriatric prescribing in the medical wards of a teaching hospital in Nepal. Pharmacoepidemiology and drug safety, 6(6), 417-21. https://doi.org/10.1002/(SICI)1099-1557(199711/12)6:6<417::AID-PDS279>3.0.CO;2-J
Joshi, M P, et al. "Geriatric prescribing in the medical wards of a teaching hospital in Nepal." Pharmacoepidemiology and drug safety vol. 6,6 (1997): 417-21. doi: https://doi.org/10.1002/(SICI)1099-1557(199711/12)6:6<417::AID-PDS279>3.0.CO;2-J
Joshi MP, Sugimoto T, Santoso B. Geriatric prescribing in the medical wards of a teaching hospital in Nepal. Pharmacoepidemiol Drug Saf. 1997 Nov;6(6):417-21. doi: 10.1002/(SICI)1099-1557(199711/12)6:6<417::AID-PDS279>3.0.CO;2-J. PMID: 15073762.
Copy Download .nbib Format: NLM
The therapeutic potential of agents acting via purine receptors.

Expert opinion on investigational drugs

Appleman JR, Erion MD.
PMID: 15991954
Expert Opin Investig Drugs. 1998 Feb;7(2):225-43. doi: 10.1517/13543784.7.2.225.

A host of physiological processes associated with the cardiovascular (CV) system, central nervous system (CNS), and a variety of other organ systems and tissues are regulated by agents, primarily adenosine (ado) and adenosine triphosphate (ATP), that act via cell-surface...

Cite
Appleman JR, Erion MD. The therapeutic potential of agents acting via purine receptors. Expert Opin Investig Drugs. 1998;7(2):225-43doi: 10.1517/13543784.7.2.225.
Appleman, J. R., & Erion, M. D. (1998). The therapeutic potential of agents acting via purine receptors. Expert opinion on investigational drugs, 7(2), 225-43. https://doi.org/10.1517/13543784.7.2.225
Appleman, J R, and Erion, M D. "The therapeutic potential of agents acting via purine receptors." Expert opinion on investigational drugs vol. 7,2 (1998): 225-43. doi: https://doi.org/10.1517/13543784.7.2.225
Appleman JR, Erion MD. The therapeutic potential of agents acting via purine receptors. Expert Opin Investig Drugs. 1998 Feb;7(2):225-43. doi: 10.1517/13543784.7.2.225. PMID: 15991954.
Copy Download .nbib Format: NLM
Prophylaxis strategies for contrast-induced nephropathy.

JAMA

Pannu N, Wiebe N, Tonelli M.
PMID: 16788132
JAMA. 2006 Jun 21;295(23):2765-79. doi: 10.1001/jama.295.23.2765.

CONTEXT: Contrast-induced nephropathy is associated with significant economic and clinical consequences, including prolonged hospitalization, the requirement for dialysis, and an increased risk of death.OBJECTIVES: To summarize the current state of evidence for prophylaxis of contrast-induced nephropathy, provide evidence-based recommendations...

Cite
Pannu N, Wiebe N, Tonelli M. Prophylaxis strategies for contrast-induced nephropathy. JAMA. 2006;295(23):2765-79doi: 10.1001/jama.295.23.2765.
Pannu, N., Wiebe, N., Tonelli, M. (2006). Prophylaxis strategies for contrast-induced nephropathy. JAMA, 295(23), 2765-79. https://doi.org/10.1001/jama.295.23.2765
Pannu, Neesh, et al. "Prophylaxis strategies for contrast-induced nephropathy." JAMA vol. 295,23 (2006): 2765-79. doi: https://doi.org/10.1001/jama.295.23.2765
Pannu N, Wiebe N, Tonelli M. Prophylaxis strategies for contrast-induced nephropathy. JAMA. 2006 Jun 21;295(23):2765-79. doi: 10.1001/jama.295.23.2765. PMID: 16788132.
Copy Download .nbib Format: NLM
Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3'-digallate (TF3).

Evidence-based complementary and alternative medicine : eCAM

Chen CN, Lin CP, Huang KK, Chen WC, Hsieh HP, Liang PH, Hsu JT.
PMID: 15937562
Evid Based Complement Alternat Med. 2005 Jun;2(2):209-215. doi: 10.1093/ecam/neh081. Epub 2005 Apr 07.

SARS-CoV is the causative agent of severe acute respiratory syndrome (SARS). The virally encoded 3C-like protease (3CL(Pro)) has been presumed critical for the viral replication of SARS-CoV in infected host cells. In this study, we screened a natural product...

Cite
Chen CN, Lin CP, Huang KK, et al. Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3'-digallate (TF3). Evid Based Complement Alternat Med. 2005;2(2):209-215doi: 10.1093/ecam/neh081.
Chen, C. N., Lin, C. P., Huang, K. K., Chen, W. C., Hsieh, H. P., Liang, P. H., & Hsu, J. T. (2005). Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3'-digallate (TF3). Evidence-based complementary and alternative medicine : eCAM, 2(2), 209-215. https://doi.org/10.1093/ecam/neh081
Chen, Chia-Nan, et al. "Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3'-digallate (TF3)." Evidence-based complementary and alternative medicine : eCAM vol. 2,2 (2005): 209-215. doi: https://doi.org/10.1093/ecam/neh081
Chen CN, Lin CP, Huang KK, Chen WC, Hsieh HP, Liang PH, Hsu JT. Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3'-digallate (TF3). Evid Based Complement Alternat Med. 2005 Jun;2(2):209-215. doi: 10.1093/ecam/neh081. Epub 2005 Apr 07. PMID: 15937562; PMCID: PMC1142193.
Copy Download .nbib Format: NLM
Prevalence and treatment of breathing disorders during sleep in patients with heart failure.

Current treatment options in cardiovascular medicine

Javaheri S, Wexler L.
PMID: 16004860
Curr Treat Options Cardiovasc Med. 2005 Aug;7(4):295-306. doi: 10.1007/s11936-005-0040-0.

Heart failure is a highly prevalent disorder, with significant economic impact, and is associated with excess morbidity and mortality. One factor that may contribute to the progressively declining course of heart failure is the occurrence of recurrent episodes of...

Cite
Javaheri S, Wexler L. Prevalence and treatment of breathing disorders during sleep in patients with heart failure. Curr Treat Options Cardiovasc Med. 2005;7(4):295-306doi: 10.1007/s11936-005-0040-0.
Javaheri, S., & Wexler, L. (2005). Prevalence and treatment of breathing disorders during sleep in patients with heart failure. Current treatment options in cardiovascular medicine, 7(4), 295-306. https://doi.org/10.1007/s11936-005-0040-0
Javaheri, Shahrokh, and Wexler, Laura. "Prevalence and treatment of breathing disorders during sleep in patients with heart failure." Current treatment options in cardiovascular medicine vol. 7,4 (2005): 295-306. doi: https://doi.org/10.1007/s11936-005-0040-0
Javaheri S, Wexler L. Prevalence and treatment of breathing disorders during sleep in patients with heart failure. Curr Treat Options Cardiovasc Med. 2005 Aug;7(4):295-306. doi: 10.1007/s11936-005-0040-0. PMID: 16004860.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 603 entries